Home > Healthcare & Medical Devices > Proteomics Market

Proteomics Market Size By Component (Instruments, Consumables, Services), By Technique (Advanced Technique {Mass Spectrometry, Gel-based Technique, Protein Microarray}, Conventional Technique {ELISA, Chromatography-based Technique, Edman Sequencing, Western Blotting}, Bioinformatics Analysis), By Application (Clinical Diagnosis, Clinical Research), By End-use (Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institute, Laboratories), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI5391
  • Published Date: Nov 2022
  • Report Format: PDF

Industry Overview

Proteomics Market size surpassed USD 46.5 billion in 2022 and is poised to depict more than 10% CAGR through 2023-2032, given the escalating investment in cancer proteogenomics.

Government agencies are targeting to gain more insights into the molecular basis of cancer through large-scale proteome and genome analysis. These agencies have also been launching funds for proteomic research to identify cancer-relevant pathways. This program was intended to develop high-throughput, single-cell discovery tools, contributing to the advancement of cancer genomics and proteomics.

Get more details on this report - Request Free Sample PDF

Despite the acceleration of proteomic research, high instrument costs may hinder the industry outlook to a certain extent. Protein structuring involves the use of machines, including X-ray crystallography, and high-throughput fields to conduct protein expression, crystallization, and gene cloning. These processes require several lab hours, resulting in increased costs per sample testing. Additionally, rising costs of instruments may impede clinical proteomic research, especially in developing nations. However, the growing number of death cases due to cancer will promote the development of proteomics platforms, which may contribute to industry development.

Expansion of drug development lab operations augments proteomic consumables demand

Proteomics market from the consumables component segment is set to cross USD 83.5 billion by 2032, given the use of kits, strips, and other consumables and reagents in the examination of biological samples. Lab operations and academic institutes have also been expanding over recent years. For instance, in October 2022, Thermo Fisher Scientific Inc. unveiled plans to invest USD 59 million to expand its lab operations in the U.S. to deliver life-changing medicines. Such initiatives will drive the use of proteomic consumables to aid drug discovery.

Bioinformatics analysis to emerge as preferred technique for proteomics research

Get more details on this report - Request Free Sample PDF

Based on the technique, the proteomics market from the bioinformatics analysis segment is poised to depict over 10% CAGR through 2032. Bioinformatics is becoming an integral part of proteomics research, essential for examining protein activity, expression, modifications, and regulations. This technique adopts proteomics algorithms to manage large and varied data during the process of marker discovery. This, alongside the increase in disease outbreaks, will promote the adoption of the bioinformatics technique for proteomics over the forecast period.

Novel biomarker development to boost proteomics implementation in clinical research

Proteomics market from the clinical research application segment is projected to be worth more than USD 69 billion by 2032. The scope of proteomics in clinical research includes the identification of toxicity biomarkers from readily available biological fluids. This approach is also used for target identification & validation, efficacy, and investigations into drug action mechanisms or toxicity. The development of novel biomarkers to improve disease prognosis, diagnosis, and monitoring will therefore enhance the application scope of proteomics in clinical research.

Availability of advanced protein analysis instruments to accelerate proteomics study in labs

In terms of the end-use, the proteomics market share from the laboratories segment will register over 9% CAGR through 2032. The availability of advanced protein analysis techniques and instruments in laboratories is one of the prominent drivers for market growth. Labs also employ multiple quantitative proteomics approaches to optimize deep proteome analysis and post-translational modifications. These activities ensure the production of quality proteomics data, thereby promoting proteomics research in labs and creating lucrative opportunities for industry development.

Investments in life sciences research to fuel adoption of proteomics approach in Europe

Get more details on this report - Request Free Sample PDF

Europe proteomics market is expected to register revenue worth USD 42 billion by 2032, as a result of the mounting government funding in clinical research projects. For example, the EU-funded EPIC-XS project was introduced to bring together prominent proteomics facilities from Europe to support life sciences research in the region. This project was intended to provide access to innovative proteomics facilities, bolstering the implementation of bioinformatics and proteomics approaches in life science research in Europe.

Advanced platform development strategies to define the industry landscape

Key companies operating in the proteomics market include Seer, Inc, Biognosys AG, Creative Proteomics, SomaLogic Operating Co., Inc, Agilent Technologies, Inc, Promega Corporation, Thermo Fisher Scientific, Bruker, Bio-Rad Laboratories, Quantum-Si, Inc, PREOMICS GMBH, and Olink, among others. These companies are focusing on novel platform developments and other strategies to expand their business portfolio in the market.

Impact of COVID-19 Outbreak on proteomics market trends

In wake of the COVID-19 pandemic, several clinical studies were temporarily delayed worldwide due to the implementation of restrictions. However, despite causing disruptions in various sectors, the pandemic created significant demand for proteomics services, asserting a strong impact on market expansion. New trial models or approaches using advanced mass spectrometers for quality outcomes continued to gain momentum, especially among CROs. For instance, in 2020, the deployment of innovative technologies in mass spectrometers allowed the identification of proteins unique to COVID-19. Such attributes have generated favorable growth opportunities for the proteomics industry.

The proteomics market report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2018 to 2032 for the following segments:

By Component

  • Instruments
  • Consumables
  • Services

By Technique

  • Advanced technique
    • Mass spectrometry
    • Gel-based technique
    • Protein microarray
    • Others
  • Conventional technique
    • ELISA
    • Chromatography based technique
    • Edman sequencing
    • Western blotting
  • Bioinformatics analysis
  • Others

By Application 

  • Clinical diagnosis
  • Clinical research

By End-use

  • Pharmaceutical & biopharmaceutical companies
  • Academic & research institute
  • Laboratories
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • South Africa
    • Saudi Arabia


Authors: Rupali Swain, Subodh Kharad

Frequently Asked Questions (FAQ) :

The market size for proteomics crossed USD 46.5 billion in 2022 and is poised to depict more than 10% CAGR through 2023-2032, given the escalating investment in cancer proteogenomics.
Consumables component segment will cross USD 83.5 billion by 2032, due to the application scope of kits, strips, and other consumables in biological sample examination.
Europe proteomics market is anticipated to cross USD 42 billion by 2032, as a result of the rise in government funding for clinical life sciences research projects.
Seer, Inc, Biognosys AG, Creative ProteomicsAgilent Technologies, Inc, Promega Corporation, Thermo Fisher Scientific, Bruker, Bio-Rad Laboratories, Quantum-Si, Inc, PREOMICS GMBH, and Olink are some of the key companies included in the market.

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 325
  • Countries covered: 15
  • Pages: 250
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount